Southern Arizona Va Health Care System

Tucson, Arizona 85723

3 studies enrolling now · 51 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndromes, Acute Lung Injury, Acute Respiratory Distress Syndrome, Arthritis, Psoriatic, Atrial Fibrillation, Atrial Flutter, Breast Cancer, CRT-D Cardiac Resynchronization Therapy Defibrillator, Cardiac Resynchronization Therapy, Cardiovascular Disease, Chronic Kidney Disease (CKD)

Studies at this site

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers — Recruiting now
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent — Running, not enrolling
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
A Prospective, Randomized, Double-Blind Multicenter Study Comparing CDO Therapy to Standard MWT in the Treatment of DFUs — Completed
SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI — Stopped early
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. — Completed
Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics — Completed
LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
Micronized dHACM Injectable for the Treatment of Achille Tendonitis — Completed
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis — Completed
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment — Stopped early
Sleep Intervention During Acute Lung Injury — Completed
Lead Registry for Optim Leads — Completed
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer — Stopped early
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis — Completed
Cardiovascular Inflammation Reduction Trial — Completed
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate — Completed
Advance Cardiac Resynchronization Therapy (CRT) Registry — Completed
IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting — Completed
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) — Status unconfirmed
DermACELL in Subjects With Chronic Wounds of the Lower Extremities — Completed
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome — Completed
A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients — Completed
GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds — Completed
Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices — Completed
Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention — Completed
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery — Completed
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers — Status unconfirmed
A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA) — Stopped early
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers — Completed
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers — Completed
Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers — Stopped early
POsition of Leads in Advanced heaRt Failure: the POLAR Study — Status unconfirmed
Evaluation of a Medical Food for Chronic Wounds — Completed
Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes — Completed
Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. — Completed
Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD — Status unconfirmed
Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) — Completed
The Effect of High PCO2 Solution on Esophageal Acid Sensation — Status unconfirmed
Center for the Study of Vascular Disease in Hispanic and Native Americans — Completed
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers — Status unconfirmed
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers — Status unconfirmed
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early